SCHEMBL5221408

SCHEMBL5221408

Nc1nnccc1-c1cccc(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.46
▸ TAAR1 Q96RJ0 2/20 0.46
▸ NOTUM Q6P988 1/20 0.44
▸ FYN P06241 3/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MAP4K4 O95819 5/20 0.42
▸ CDC7 O00311 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ PRKACA P17612 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ HIPK2 Q9H2X6 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ IRAK4 Q9NWZ3 1/20 0.41
▸ MTOR P42345 1/20 0.40
▸ CHEK2 O96017 1/20 0.40
▸ ADORA2A P29274 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223234 0.79 DHFR (0.51) NOTUMMAP4K4ADORA2AADORA1
SCHEMBL28075469 0.78 TDO2 (0.43) NOTUMMAP4K4PRKACACDK2GSK3B
SCHEMBL22588702 0.77 SMARCA2 (0.53) NOTUMMAP4K4GSK3BCLK4ADORA2A
SCHEMBL17555726 0.76 FYN (0.49) KDM4ETAAR1FYNMEN1MAPT
Hydrochloric Acid SCHEMBL27209691 0.76 SMARCA2 (0.52) MAP4K4GSK3BCLK4ADORA2AADORA1
SCHEMBL21994858 0.75 KDM4E (0.45) KDM4ETAAR1NOTUMFYNMEN1
SCHEMBL18748036 0.70 ADORA2A (0.57) KDM4ETAAR1NOTUMMEN1MAPT
SCHEMBL27862933 0.69 GABRG2 (0.48) KDM4ETAAR1NOTUMMEN1MAPT
SCHEMBL28878344 0.69 NOTUM (0.44) KDM4ETAAR1NOTUMADORA2AADORA1
SCHEMBL4470993 0.69 CHEK2 (0.56) KDM4ETAAR1FYNMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1827434-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER Amgen Inc. (US) 2007-09-05 — — EP claimed
WO-2006060318-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER AMGEN INC. (US) 2006-06-08 — — WO claimed
Send feedback